Risk acceptance in multiple sclerosis patients on natalizumab treatment.

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

<h4>Objective</h4>We aimed to investigate the ability of natalizumab (NTZ)-treated patients to assume treatment-associated risks and the factors involved in such risk acceptance.<h4>Methods</h4>From a total of 185 patients, 114 patients on NTZ as of July 2011 carried out a co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carmen Tur, Mar Tintoré, Ángela Vidal-Jordana, Denis Bichuetti, Pablo Nieto González, María Jesús Arévalo, Georgina Arrambide, Elisenda Anglada, Ingrid Galán, Joaquín Castilló, Carlos Nos, Jordi Río, María Isabel Martín, Manuel Comabella, Jaume Sastre-Garriga, Xavier Montalban
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/840274e7d6b24193b1129c06899c0145
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares